bioAffinity
  • Home
  • Publications
  • News
  • About Us
  • Videos
  • Contact
  • Investor Relations
Select Page

bioAffinity Technologies Attends NAVREF Industry Partner Quarterly Meeting

by Maria Zannes | Jun 12, 2023 | Events

bioAffinity Technologies President and CEO Maria Zannes is attending the National Association of Veterans’ Research and Education Foundations’ (NAVREF) quarterly meeting of industry partners in Portland, OR, June 12-13. NAVREF is a non-profit organization dedicated to...

bioAffinity Technologies Holds Annual Meeting of Stockholders

by Maria Zannes | Jun 6, 2023 | Events

bioAffinity Technologies, Inc. held its 2023 Annual Meeting of Stockholders on June 6, 2023, both in person at the Company’s principal office in San Antonio, TX, and virtually via a live webcast on June 6, 2023. Shareholders were entitled to cast one vote per share of...

bioAffinity Technologies Presents Research Findings at CYTO 2023

by Maria Zannes | May 22, 2023 | Press Releases

SAN ANTONIO, Texas (May 22, 2023) – bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer and other diseases of the lung, today will present the poster “Development of...

bioAffinity Technologies Reports First Quarter 2023 Financial Results

by Maria Zannes | May 15, 2023 | Press Releases

SAN ANTONIO, Texas (May 15, 2023) – bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer and other diseases of the lung, today reported financial results for the three...

After going public, SA company making C-suite change, adding former Amazon executive

by Maria Zannes | May 8, 2023 | Articles, News

bioAffinity Technologies CEO Maria Zannes says the company has made a key hire May 4, 2023 As published in the San Antonio Business Journal By: W. Scott Bailey – Senior Reporter, San Antonio Business Journal BioAffinity Technologies Inc. has made a key change in its...
« Older Entries
Next Entries »

Categories

  • Articles (18)
  • Events (38)
  • News (43)
  • Press Releases (70)
  • Publications (16)

Recent Posts

  • bioAffinity Technologies Acquires Laboratory Assets of Precision Pathology Services September 19, 2023
  • bioAffinity Technologies to Participate in the H.C. Wainwright Global Investment Conference September 7, 2023
  • bioAffinity Technologies Reports Second Quarter 2023 Financial Results and Provides Business Update August 10, 2023
  • AMA Issues CPT Code for bioAffinity Technologies’ CyPath® Lung Test for Early-Stage Lung Cancer July 12, 2023
  • bioAffinity Technologies Presents Research Findings at UMass RNA Therapeutics Symposium June 15, 2023

Learn About CyPath Lung

CyPath Lung Test

Main Menu

  • Home
  • Publications
  • News
  • About Us
  • Videos
  • Contact
  • Investor Relations
Copyright © 2023 bioAffinity Technologies, Inc.